Additionally, ROSs act as second messengers, activating NF-κB, AP-1, and matrix metalloproteinase-1 (MMP1), upregulating IL-8, VEGF, and iNOS, thereby promoting inflammation, proliferation, survival, angiogenesis, and tumor invasion/metastasis. This evidence concerns the gene CXCL8 and neoplasm.